168 related articles for article (PubMed ID: 30795854)
1. Improved radiosynthesis and preliminary in vivo evaluation of the
Stéen EJL; Jørgensen JT; Petersen IN; Nørregaard K; Lehel S; Shalgunov V; Birke A; Edem PE; L'Estrade ET; Hansen HD; Villadsen J; Erlandsson M; Ohlsson T; Yazdani A; Valliant JF; Kristensen JL; Barz M; Knudsen GM; Kjær A; Herth MM
Bioorg Med Chem Lett; 2019 Apr; 29(8):986-990. PubMed ID: 30795854
[TBL] [Abstract][Full Text] [Related]
2. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Evaluation of a Low-Molecular-Weight (11)C-Labeled Tetrazine for Pretargeted PET Imaging Applying Bioorthogonal in Vivo Click Chemistry.
Denk C; Svatunek D; Mairinger S; Stanek J; Filip T; Matscheko D; Kuntner C; Wanek T; Mikula H
Bioconjug Chem; 2016 Jul; 27(7):1707-12. PubMed ID: 27308894
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging.
Edem PE; Sinnes JP; Pektor S; Bausbacher N; Rossin R; Yazdani A; Miederer M; Kjær A; Valliant JF; Robillard MS; Rösch F; Herth MM
EJNMMI Res; 2019 May; 9(1):49. PubMed ID: 31140047
[TBL] [Abstract][Full Text] [Related]
5.
Stéen EJL; Jørgensen JT; Johann K; Nørregaard K; Sohr B; Svatunek D; Birke A; Shalgunov V; Edem PE; Rossin R; Seidl C; Schmid F; Robillard MS; Kristensen JL; Mikula H; Barz M; Kjær A; Herth MM
ACS Nano; 2020 Jan; 14(1):568-584. PubMed ID: 31820928
[TBL] [Abstract][Full Text] [Related]
6. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.
Mandikian D; Rafidi H; Adhikari P; Venkatraman P; Nazarova L; Fung G; Figueroa I; Ferl GZ; Ulufatu S; Ho J; McCaughey C; Lau J; Yu SF; Prabhu S; Sadowsky J; Boswell CA
MAbs; 2018; 10(8):1269-1280. PubMed ID: 30199303
[TBL] [Abstract][Full Text] [Related]
7. Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction.
Rossin R; van Duijnhoven SM; Läppchen T; van den Bosch SM; Robillard MS
Mol Pharm; 2014 Sep; 11(9):3090-6. PubMed ID: 25077373
[TBL] [Abstract][Full Text] [Related]
8. [
García-Vázquez R; Battisti UM; Shalgunov V; Schäfer G; Barz M; Herth MM
Macromol Rapid Commun; 2022 Jun; 43(12):e2100655. PubMed ID: 34888977
[TBL] [Abstract][Full Text] [Related]
9. Pretargeted PET Imaging Using a Bioorthogonal
Billaud EMF; Belderbos S; Cleeren F; Maes W; Van de Wouwer M; Koole M; Verbruggen A; Himmelreich U; Geukens N; Bormans G
Bioconjug Chem; 2017 Dec; 28(12):2915-2920. PubMed ID: 29191024
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Structurally Diverse
Adhikari K; Dewulf J; Vangestel C; Van der Veken P; Stroobants S; Elvas F; Augustyns K
ACS Omega; 2023 Oct; 8(41):38252-38262. PubMed ID: 37867688
[No Abstract] [Full Text] [Related]
11. Evaluation of Organo [
Otaru S; Imlimthan S; Sarparanta M; Helariutta K; Wähälä K; Airaksinen AJ
Molecules; 2020 Mar; 25(5):. PubMed ID: 32156020
[TBL] [Abstract][Full Text] [Related]
12. Development of a (11)C-labeled tetrazine for rapid tetrazine-trans-cyclooctene ligation.
Herth MM; Andersen VL; Lehel S; Madsen J; Knudsen GM; Kristensen JL
Chem Commun (Camb); 2013 May; 49(36):3805-7. PubMed ID: 23535705
[TBL] [Abstract][Full Text] [Related]
13. Development of the First Aliphatic
Battisti UM; Bratteby K; Jørgensen JT; Hvass L; Shalgunov V; Mikula H; Kjær A; Herth MM
J Med Chem; 2021 Oct; 64(20):15297-15312. PubMed ID: 34649424
[TBL] [Abstract][Full Text] [Related]
14. Dual Radionuclide Theranostic Pretargeting.
Keinänen O; Brennan JM; Membreno R; Fung K; Gangangari K; Dayts EJ; Williams CJ; Zeglis BM
Mol Pharm; 2019 Oct; 16(10):4416-4421. PubMed ID: 31483993
[TBL] [Abstract][Full Text] [Related]
15. Pretargeted PET of Osteodestructive Lesions in Dogs.
Maitz CA; Delaney S; Cook BE; Genady AR; Hoerres R; Kuchuk M; Makris G; Valliant JF; Sadeghi S; Lewis JS; Hennkens HM; Bryan JN; Zeglis BM
Mol Pharm; 2022 Sep; 19(9):3153-3162. PubMed ID: 35635337
[TBL] [Abstract][Full Text] [Related]
16. Diabody Pretargeting with Click Chemistry In Vivo.
van Duijnhoven SM; Rossin R; van den Bosch SM; Wheatcroft MP; Hudson PJ; Robillard MS
J Nucl Med; 2015 Sep; 56(9):1422-8. PubMed ID: 26159589
[TBL] [Abstract][Full Text] [Related]
17. Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody.
Rossin R; Läppchen T; van den Bosch SM; Laforest R; Robillard MS
J Nucl Med; 2013 Nov; 54(11):1989-95. PubMed ID: 24092936
[TBL] [Abstract][Full Text] [Related]
18. Tetrazine Glycoconjugate for Pretargeted Positron Emission Tomography Imaging of
Auchynnikava T; Äärelä A; Liljenbäck H; Järvinen J; Andriana P; Kovacs L; Rautio J; Rajander J; Virta P; Roivainen A; Li XG; Airaksinen AJ
ACS Omega; 2023 Dec; 8(48):45326-45336. PubMed ID: 38075748
[TBL] [Abstract][Full Text] [Related]
19. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.
Zeglis BM; Brand C; Abdel-Atti D; Carnazza KE; Cook BE; Carlin S; Reiner T; Lewis JS
Mol Pharm; 2015 Oct; 12(10):3575-87. PubMed ID: 26287993
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a
Edem PE; Jørgensen JT; Nørregaard K; Rossin R; Yazdani A; Valliant JF; Robillard M; Herth MM; Kjaer A
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
